← Open Payments lookup

LAIRA COWPER: Open Payments

NPI 1629694674 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,003 in 53 payments from 10 companies in 2025. Trend: 2023 $765 · 2024 $1,539 · 2025 $1,003

Food & beverage: $1,003
CompanyPaymentsAmount
ABBVIE INC.20$316
Lundbeck LLC8$172
Vanda Pharmaceuticals Inc.11$165
Axsome Therapeutics, Inc.4$113
Neurocrine BioSciences, Inc.2$64
E.R. Squibb & Sons, L.L.C.3$53
Takeda Pharmaceuticals U.S.A., Inc.2$46
Alkermes, Inc.1$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Avadel CNS Pharmaceuticals, LLC1$19

Products named: VRAYLAR, REXULTI, FANAPT, Auvelity, INGREZZA, COBENFY, TRINTELLIX, LYBALVI.

Industry payments across CO — which companies pay providers there.